Is a
Clinical Study attributes
NCT Number
Trial Recruitment Size
210
Trial Sponsor
Clinical Trial Start Date
September 25, 2018
0Primary Completion Date
September 28, 2021
0Study Completion Date
September 28, 2021
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Intervention Type
Biological0
Intervention Name
MGD0140
Interventional Trial Phase
Phase 10
Official Name
A Phase 1 Study to Evaluate the Safety, Immunologic and Virologic Responses of MGD014 Therapy in HIV-Infected Individuals on Suppressive Antiretroviral Therapy0
Last Updated
September 2, 2022
0Allocation Type
Non-Randomized0
Intervention Model
Sequential Assignment0
Masking Type
None (Open Label)0
Study summary
This is a Phase 1, open-label single-center study to determine the safety of MGD014 in participants with human immunodeficiency virus (HIV) infection on stable suppressive antiretroviral therapy (ART).
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
